Nagwa Shehata

Dr. Nagwa Shehata


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in Analytical Biochemistry
Verified
Journal Article
Closed access
ANAhmed Ibrahim Nossier
Ahmed Ibrahim Nossier
NSNagwa Shehata
Nagwa Shehata
SMSuzy Mahmoud Morsy
Suzy Mahmoud Morsy
DSDoaa Fayez Saeed
Doaa Fayez Saeed
NENaglaa Mohamed Elsayed
Naglaa Mohamed Elsayed
SESanaa Eissa
Sanaa Eissa

13 May 2022 in Cancer Biomarkers
Verified
Journal Article
Closed access
PDF file
AGAbdullah Gibriel
Abdullah Gibriel
MIManal Fouad Ismail
Manal Fouad Ismail
HSHameis Sleem
Hameis Sleem
NZNaglaa Zayed
Naglaa Zayed
AYAyman Yosry
Ayman Yosry
NSNagwa Shehata
Nagwa Shehata
BACKGROUND: Chronic HCV infection progresses to fibrosis, cirrhosis and hepatocellular carcinoma (HCC). The latter represents the third most common cause for cancer mortality. Currently, there is no reliable non-invasive biomarker for diagnosis of HCV mediated disorders. OBJECTIVE: Profiling expression signature for circulatory miRNAs in the plasma of 167 Egyptian patients (40 healthy, 48 HCV fibrotic, 39 HCV cirrhotic and 40 HCV-HCC cases). METHODS: QRTPCR was used to quantify expression signature for circulatory miRNAs. RESULTS: MiR-676 and miR-650 were powerful in discriminating cirrhotic and late fibrosis from HCC. MiR-650 could distinguish mild (f0-f1) and advanced (f2-f3) fibrosis from HCC cases. MiR-650 and miR-147b could distinguish early fibrosis from healthy controls meanwhile miR-676 and miR-147b could effectively distinguish between mild chronic and (f1-f3) cases from healthy individuals. All studied miRNAs, except miR-512, can differentiate between (f0-f3) cases and healthy controls. Multivariate logistic regression revealed three potential miRNA panels for effective differentiation of HCC, cirrhotic and chronic liver cases. MiR-676-3p and miR-512-5p were significantly correlated in (f1-f3) fibrosis meanwhile miR-676 and miR-512 could differentiate between cirrhosis and (f0-f3) cases. Both miR-650 and miR-512-5p were positively correlated in the cirrhotic group and in (f0-f4) group. Putative targets for investigated miRNAs were also determined. CONCLUSIONS: Investigated miRNAs could assist in staging and diagnosis of HCV associated disorders.

1 November 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
NSNagwa Shehata
Nagwa Shehata
DEDina Mohamed Abd El-Salam
Dina Mohamed Abd El-Salam
RHRoqaya Mahmoud Hussein
Roqaya Mahmoud Hussein
SRSherine Maher Rizk
Sherine Maher Rizk
3-nitropropionic acid (3-NP) is a potent mitochondrial inhibitor mycotoxin. Systemic administration of 3-NP can induce Huntington’s disease (HD)-like symptoms in experimental animals. Safranal (Safr) that is found in saffron essential oil has antioxidant, anti-inflammatory and anti-apoptotic actions. Candesartan (Cands) is an angiotensin receptor blocker that has the potential to prevent cognitive deficits. The present study aims to investigate the potential neuroprotective efficacy of Safr or Cands in 3-NP-induced rat model of HD. The experiments continued for nine consecutive days. Rats were randomly assigned into seven groups. The first group (Safr-control) was daily intraperitoneally injected with paraffin oil. The second group (Cands- and 3-NP-control) daily received an oral dose of 0.5% carboxymethylcellulose followed by an intraperitoneal injection of 0.9% saline. The third and fourth groups received a single daily dose of 50 mg/kg Safr (intraperitoneal) and 1 mg/kg Cands (oral), respectively. The sixth group was daily treated with 50 mg Safr kg/day (intraperitoneal) and was intraperitoneally injected with 20 mg 3-NP/ kg, from the 3rd till the 9th day. The seventh group was daily treated with 1 mg Cands /kg/day (oral) and was intraperitoneally injected with 20 mg 3-NP/ kg, from the 3rd till the 9th day. The present results revealed that 3-NP injection induced a considerable body weight loss, impaired memory and locomotor activity, reduced striatal monoamine levels. Furthermore, 3-NP administration remarkably increased striatal malondialdehyde and nitric oxide levels, whereas markedly decreased the total antioxidant capacity. Moreover, 3-NP significantly upregulated the activities of inducible nitric oxide synthase and caspase-3 as well as the Fas ligand, in striatum. On the contrary, Safr and Cands remarkably alleviated the above-mentioned 3-NP-induced alterations. In conclusion, Safr and Cands may prevent or delay the progression of HD and its associated impairments through their antioxidant, anti-inflammatory, anti-apoptotic and neuromodulator effects.

11 May 2022 in Journal of Food Biochemistry
Verified
Journal Article
Closed access
NSNagwa Shehata
Nagwa Shehata
MAMai A. Abdelsamad
Mai A. Abdelsamad
HAHebat Allah Ahmed Amin
Hebat Allah Ahmed Amin
NSNermin Abdel Hamid Sadik
Nermin Abdel Hamid Sadik
ASAmira A. Shaheen
Amira A. Shaheen

19 February 2023 in Journal of Biochemical and Molecular Toxicology
Verified
Journal Article
Closed access
ASAsmaa O. Sana‐Eldine
Asmaa O. Sana‐Eldine
HAHanan M. Abdelgawad
Hanan M. Abdelgawad
NKNahla S. Kotb
Nahla S. Kotb
NSNagwa Shehata
Nagwa Shehata

30 January 2022 in Journal of Food Biochemistry
Verified
Journal Article
Open access
PDF file
NSNagwa Shehata
Nagwa Shehata
SZSeham Mohammed Abo Zeid
Seham Mohammed Abo Zeid
SASamy A. Abd El Aziz
Samy A. Abd El Aziz
HAHanan Muhammad Abdelgawad
Hanan Muhammad Abdelgawad
Diabetes is the most common endocrine disorder contributing to high morbidity and mortality globally. Due to the side effects reported for anti-diabetic drugs, there is a rising interest in herbal medicine for diabetes mitigation. However, rare studies were performed to analyze the molecular effects of natural agents on diabetes. Therefore, this study is the first to assess the possible ameliorating effects of avocado and cinnamon extracts on streptozotocin (STZ)-induced disturbances in the gene expression of PDX1 and Ins1 in type-2 diabetic rats, in comparison to metformin. A total number of 50 male Albino rats were randomly divided into five groups; normal control, STZ-induced diabetic group (65 mg/kg b.w divided into three doses 5 days apart), three other STZ-diabetic groups were treated orally for 6 weeks with metformin (500 mg/kg b.w/day), an avocado fruit ethanolic extract (300 mg/kg b.w/day), or a cinnamon aqueous extract (200 mg/kg b.w/day). All rats were fasted overnight then euthanized, blood was collected, and serum was separated for biochemical analyses. The pancreas was processed for the evaluation of PDX1 and Ins1 gene expression by qRT-PCR. Oral administration of the avocado/cinnamon extract significantly improved the altered levels of blood glucose, insulin, lipid profile, and total antioxidant capacity (TAC) and upregulated the pancreatic expression of PDX1 and Ins1 genes. In conclusion, this study added another mechanism of anti-diabetic action for the plant extracts via upregulating the gene expression of PDX1 and Ins1 in STZ-diabetic rats. Metformin has a more profound effect than the plant extracts; however, cinnamon has a comparable effect. Practical applications Diabetes is a worldwide chronic serious problem; therefore, different efficacious drug treatments are currently available. However, several side effects of these drugs also negatively affect patient welfare. Therefore, the present study provides an additive/adjunct biochemical rationale for further natural intervention strategy for type-2 diabetes through the introduction of plant-derived products that revealed a wide range of therapeutic effects without causing untoward actions. This study revealed that cinnamon and avocado extracts exhibited marked anti-diabetic and antioxidant effects in rats, as compared to the standard drug, metformin. These results augmented the previous ones and added a new molecular mechanism of action through upregulation of Ins1 and PDX1 in type-2 diabetic rats.